Cardlytics Stock Analysis

CDLX Stock  USD 3.93  0.13  3.42%   
Cardlytics is undervalued with Real Value of 7.06 and Target Price of 17.0. The main objective of Cardlytics stock analysis is to determine its intrinsic value, which is an estimate of what Cardlytics is worth, separate from its market price. There are two main types of Cardlytics' stock analysis: fundamental analysis and technical analysis.
The Cardlytics stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Cardlytics is usually not traded on Memorial Day, Juneteenth Holiday, Independence Day, Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday. Cardlytics Stock trading window is adjusted to America/New York timezone.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cardlytics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
For more information on how to buy Cardlytics Stock please use our How to Invest in Cardlytics guide.

Cardlytics Stock Analysis Notes

About 62.0% of the company shares are held by institutions such as insurance companies. The book value of Cardlytics was currently reported as 1.38. The company recorded a loss per share of 6.4. Cardlytics had not issued any dividends in recent years. Cardlytics, Inc. operates an advertising platform in the United States and the United Kingdom. The company was incorporated in 2008 and is headquartered in Atlanta, Georgia. Cardlytics operates under Advertising Agencies classification in the United States and is traded on NASDAQ Exchange. It employs 710 people. For more info on Cardlytics please contact Karim Temsamani at 888 792 5802 or go to https://www.cardlytics.com.

Cardlytics Quarterly Total Revenue

67.06 Million

Cardlytics Investment Alerts

Cardlytics had very high historical volatility over the last 90 days
Cardlytics has high likelihood to experience some financial distress in the next 2 years
Cardlytics currently holds 266.11 M in liabilities with Debt to Equity (D/E) ratio of 0.42, which is about average as compared to similar companies. Cardlytics has a current ratio of 0.88, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Cardlytics' use of debt, we should always consider it together with its cash and equity.
The entity reported the previous year's revenue of 309.2 M. Net Loss for the year was (134.7 M) with profit before overhead, payroll, taxes, and interest of 115.42 M.
Cardlytics currently holds about 157.04 M in cash with (185 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.77, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Roughly 62.0% of Cardlytics shares are held by institutions such as insurance companies
Latest headline from MacroaxisInsider: Disposition of 43750 shares by Alexis DeSieno of Cardlytics subject to Rule 16b-3

Cardlytics Upcoming and Recent Events

Earnings reports are used by Cardlytics to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period..
6th of March 2024
Upcoming Quarterly Report
View
31st of December 2023
Next Fiscal Quarter End
View

Cardlytics Largest EPS Surprises

Earnings surprises can significantly impact Cardlytics' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2024-08-07
2024-06-30-0.13-0.15-0.0215 
2024-05-08
2024-03-31-0.11-0.090.0218 
2024-03-14
2023-12-310.120.140.0216 
View All Earnings Estimates

Cardlytics Environmental, Social, and Governance (ESG) Scores

Cardlytics' ESG score is a quantitative measure that evaluates Cardlytics' performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of Cardlytics' operations that may have significant financial implications and affect Cardlytics' stock price as well as guide investors towards more socially responsible investments.

Cardlytics Stock Institutional Investors

Shares
Nuveen Asset Management, Llc2024-06-30
665.5 K
Dimensional Fund Advisors, Inc.2024-09-30
638 K
D. E. Shaw & Co Lp2024-09-30
573.3 K
Baillie Gifford & Co Limited.2024-09-30
567.4 K
General Equity Holdings Lp2024-09-30
533.5 K
Ubs O'connor Llc2024-09-30
450 K
Renaissance Technologies Corp2024-09-30
410.9 K
Pb Investment Partners, L.p.2024-09-30
397.1 K
Charles Schwab Investment Management Inc2024-09-30
390.3 K
Morgan Stanley - Brokerage Accounts2024-06-30
4.3 M
Blackrock Inc2024-06-30
3.2 M
Note, although Cardlytics' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Cardlytics Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 199.73 M.

Cardlytics Profitablity

The company has Profit Margin (PM) of (0.94) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.25) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.25.
Last ReportedProjected for Next Year
Return On Tangible Assets(0.57)(0.60)
Return On Capital Employed(0.34)(0.35)
Return On Assets(0.23)(0.25)
Return On Equity(1.00)(1.05)

Management Efficiency

Cardlytics has return on total asset (ROA) of (0.0762) % which means that it has lost $0.0762 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.8612) %, meaning that it created substantial loss on money invested by shareholders. Cardlytics' management efficiency ratios could be used to measure how well Cardlytics manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.6 in 2024. Return On Capital Employed is likely to drop to -0.35 in 2024. At this time, Cardlytics' Net Tangible Assets are fairly stable compared to the past year. Intangibles To Total Assets is likely to rise to 0.62 in 2024, whereas Total Assets are likely to drop slightly above 440 M in 2024.
Last ReportedProjected for Next Year
Book Value Per Share 3.69  3.88 
Tangible Book Value Per Share(5.54)(5.81)
Enterprise Value Over EBITDA(5.15)(5.41)
Price Book Value Ratio 2.49  3.76 
Enterprise Value Multiple(5.15)(5.41)
Price Fair Value 2.49  3.76 
Enterprise Value510.3 M484.8 M
The decision-making processes within Cardlytics are key to its success in a competitive market. By evaluating these processes, we assess the stock's potential for future gains.
Operating Margin
(0.25)
Profit Margin
(0.94)
Beta
1.618
Return On Assets
(0.08)
Return On Equity
(1.86)

Technical Drivers

As of the 25th of November, Cardlytics shows the Mean Deviation of 3.8, risk adjusted performance of 0.0372, and Downside Deviation of 5.69. Cardlytics technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.

Cardlytics Price Movement Analysis

The output start index for this execution was two with a total number of output elements of fifty-nine. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Cardlytics middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Cardlytics. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Cardlytics Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Cardlytics insiders, such as employees or executives, is commonly permitted as long as it does not rely on Cardlytics' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Cardlytics insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Cardlytics Outstanding Bonds

Cardlytics issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Cardlytics uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Cardlytics bonds can be classified according to their maturity, which is the date when Cardlytics has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Cardlytics Predictive Daily Indicators

Cardlytics intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Cardlytics stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Cardlytics Corporate Filings

F4
15th of November 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
13A
12th of November 2024
An amended filing to the original Schedule 13G
ViewVerify
8K
6th of November 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
8K
4th of November 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
13A
24th of October 2024
An amended filing to the original Schedule 13G
ViewVerify
F4
3rd of October 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
F4
9th of September 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
F4
22nd of August 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify

Cardlytics Forecast Models

Cardlytics' time-series forecasting models are one of many Cardlytics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Cardlytics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Cardlytics Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Cardlytics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Cardlytics shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Cardlytics. By using and applying Cardlytics Stock analysis, traders can create a robust methodology for identifying Cardlytics entry and exit points for their positions.
Last ReportedProjected for Next Year
Pretax Profit Margin(0.44)(0.46)
Operating Profit Margin(0.44)(0.46)
Net Loss(0.44)(0.46)
Gross Profit Margin 0.42  0.30 

Current Cardlytics Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Cardlytics analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Cardlytics analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
17.0Hold6Odds
Cardlytics current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Cardlytics analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Cardlytics stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Cardlytics, talking to its executives and customers, or listening to Cardlytics conference calls.
Cardlytics Analyst Advice Details

Cardlytics Stock Analysis Indicators

Cardlytics stock analysis indicators help investors evaluate how Cardlytics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Cardlytics shares will generate the highest return on investment. By understating and applying Cardlytics stock analysis, traders can identify Cardlytics position entry and exit signals to maximize returns.
Begin Period Cash Flow122 M
Long Term Debt257.6 M
Common Stock Shares Outstanding36.5 M
Total Stockholder Equity134.8 M
Quarterly Earnings Growth Y O Y-0.567
Property Plant And Equipment Net10.6 M
Cash And Short Term Investments91.8 M
Cash91.8 M
Accounts Payable4.4 M
Net Debt174.3 M
50 Day M A3.7489
Total Current Liabilities171.1 M
Other Operating Expenses444.9 M
Non Current Assets Total350.2 M
Non Currrent Assets Other2.7 M
Stock Based Compensation41 M

Additional Tools for Cardlytics Stock Analysis

When running Cardlytics' price analysis, check to measure Cardlytics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cardlytics is operating at the current time. Most of Cardlytics' value examination focuses on studying past and present price action to predict the probability of Cardlytics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cardlytics' price. Additionally, you may evaluate how the addition of Cardlytics to your portfolios can decrease your overall portfolio volatility.